Congratulations to Maria Belvisi, SVP and Head of Research and Early Development Respiratory and Immunology, for being named one of Endpoints News 20 Outstanding Women in BioPharma 2021. This is testament to Maria’s achievements in both academia and industry. We appreciate her talent and passion in following the science to deliver life-changing medicines for people with chronic respiratory and immune-mediated diseases.
In a new World Economic Forum blog post, Pascal Soriot, CEO, discusses how society must apply learnings from the pandemic to fight climate change - including the power of science and innovation, the importance of global partnerships and the need to act at pace and scale.
We're pleased to announce the appointment of Dr. Susan Galbraith as EVP, Oncology R&D following the passing of José Baselga earlier this year. Susan is an outstanding oncologist with a track record of delivering breakthrough science over the past decade at AstraZeneca.
Congratulations to our colleagues for their recognition in the Queen’s Birthday Honours. Thank you for your hard work and dedication to sharing expertise and scientific knowledge in service to life sciences and the response to the pandemic in the UK and around the world.
The events of the last 18 months have resulted in the greatest public health challenge of our generation, but the impact of the #ClimateEmergency has the potential to be greater still, damaging our planet irreversibly. We know the climate crisis is impacting human health – from air pollution to flooding, extreme heat to drought – and we are seeing a rise in chronic conditions such as heart disease, lung cancer, and respiratory illnesses. At AstraZeneca, we are on track to achieving our ambition of zero carbon emissions from our global operations by 2025 and ensuring our value chain is carbon negative by 2030. We’ve already reduced our greenhouse gas emissions by 60% since 2015. This year, with G7, G20, and COP26, there is a unique opportunity to achieve greater global collaboration. 2021 is a critical year and we are at a critical point. We have an opportunity to ‘reset’ to create a more sustainable world - together.
“We’re focused on fostering a vibrant culture where everyone is respected and has a sense of true belonging.” - Chris Maddock, co-sponsor of AZPride, our LGBTQIA+ employee resource group #Pride2021
We’re proud to be included in the Financial Times' list of Europe’s Climate Leaders, recognising our progress in reducing greenhouse gas (GHG) emissions. Through our bold Ambition Zero Carbon strategy we’ve brought forward our decarbonisation plans by more than decade - we’re committed to being carbon neutral across all our global operations by 2025, and carbon negative across our value chain by 2030.
We are deeply saddened by the news that José Baselga, EVP Oncology R&D, has passed away. An outstanding scientific leader, José leaves a lasting legacy in the scientific community and here at AstraZeneca. He set our Oncology R&D function on a remarkable trajectory, and his visionary leadership, deep scientific expertise and strategic insight have delivered so many achievements that will benefit patients’ lives in the years to come. We send our condolences to his family.
As a founding partner of the World Economic Forum Partnering for Racial Justice in Business coalition, we are joining forces with 47 companies across 13 industries to eradicate racism in the workplace #DavosAgenda
We are delighted to be named Glassdoor UK Best Places to Work in 2021. We work to offer colleagues a great place to work, because without them, we can’t create solutions that can make an impact to patient lives. Thanks to our team for sharing your feedback and making this possible!